Also on Trial Friend:Geographic Atrophy pageMatch Me
All 42 Geographic Atrophy trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic AtrophyMost sites in California, Texas and FloridaRecruitingPhase 3Ages 50-85Regeneron Pharmaceuticals147US sites
34 states - A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular DegeneratioMost sites in Texas, California and FloridaRecruitingPhase 2Ages 60+Apellis Pharmaceuticals78US sites
24 states - Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMDMost sites in Texas, California and FloridaRecruitingPhase 2Ages 55+ONL Therapeutics56US sites
22 states - A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)Most sites in California, Texas and FloridaRecruitingPhase 2/3Ages 60+Janssen Research & Development45US sites
23 states - A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular DegenerationMost sites in Texas, California and FloridaRecruitingPhase 1/2Ages 60+Sanofi31US sites
12 states - Phase 2 Study of ADX-038 in Participants With Geographic AtrophyMost sites in Texas, California and ArizonaRecruitingPhase 2Ages 60+ADARx Pharmaceuticals20US sites
7 states - A Study in Adults With Geographic AtrophyMost sites in Texas, California and MarylandRecruitingPhase 2Ages 60+Sitala Bio16US sites
11 states - A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular DegenerationMost sites in California, Florida and TexasRecruitingPhase 2Ages 50+Novartis Pharmaceuticals16US sites
8 states - A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251Most sites in California, Texas and FloridaRecruitingPhase 2Ages 50+Genentech15US sites
12 states - A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular DegenerationMost sites in California, Florida and GeorgiaRecruitingPhase 1Ages 50+Astellas Institute for Regenerative Medicine13US sites
11 states - A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular DegenerationMost sites in Ohio, Arizona and TexasRecruitingPhase 1/2Ages 55+Biojiva11US sites
7 states - Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMDMost sites in California, Florida and MassachusettsRecruitingAges 65+VisionCare10US sites
9 states - A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)Most sites in Illinois, North Carolina and NevadaRecruitingAges 55+Complement Therapeutics8US sites
6 states - Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular DegenerationMost sites in Texas, California and ConnecticutRecruitingAges 60+i-Lumen Scientific AUS PTY7US sites
6 states - A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)Most sites in California, Texas and IllinoisRecruitingPhase 2Ages 55-90Regenerative Patch Technologies5US sites
3 states - A Study to Assess the Efficacy and Safety of RO7965032 in Participants With Geographic Atrophy Secondary to Age-Related Macular DegenerationMost sites in California, North Carolina and PennsylvaniaRecruitingPhase 2Ages 50+Genentech5US sites
5 states - Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult ParticipantsMost sites in Texas, Colorado and MassachusettsRecruitingPhase 1Ages 50+Regeneron Pharmaceuticals5US sites
3 states - Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular DegenerationMost sites in Texas, Indiana and NevadaRecruitingPhase 1/2Ages 50+AbbVie5US sites
3 states - An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)Most sites in Indiana, Nevada and TexasRecruitingPhase 1/2Ages 55+Complement Therapeutics4US sites
4 states - Phase 1 Study of C.001 in Retinal DegenerationOnly in CaliforniaRecruitingPhase 1Ages 18+Cellio Therapeutics3US sites
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Who runs the Geographic Atrophy trials in the US, and what stage they are in
Of the 35 Geographic Atrophy trials with a US site, 4 are in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 20 of them. The remaining 11 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 29 of them, and universities, hospitals, foundations and government groups run 6. The sponsors with the most are Complement Therapeutics (2), Genentech (2) and Ray Therapeutics (2). The most recently listed one first appeared on ClinicalTrials.gov on October 1, 2026.
Geographic Atrophy trials in the US, state by state
Of the 35 Geographic Atrophy trials with a US site, 1 accepts children under 18. Its open sites are in Pennsylvania. A trial counts once in each state where it has an open site, and some trials accept both children and adults.
Show the other 29 states
US hospitals running the most Geographic Atrophy trials
Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Geographic Atrophy.
- Sierra Eye AssociatesReno, Nevada7 trials
- Austin Retina AssociatesAustin, Texas5 trials
- Piedmont Eye CenterLynchburg, Virginia5 trials
- Retina Foundation of the SouthwestDallas, Texas5 trials
- Duke Eye CenterDurham, North Carolina4 trials
- Erie Retina ResearchErie, Pennsylvania4 trials
- Retina Consultants San DiegoPoway, California4 trials
- Retina Vitreous Associates of FloridaSt. Petersburg, Florida4 trials
- Retina-Vitreous Associates Medical GroupBeverly Hills, California4 trials
- Associated Retina ConsultantsPhoenix, Arizona3 trials
Help getting to a Geographic Atrophy trial far from home
Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.
These nonprofits also help patients reach care, and each one sets its own rules.
- Mercy Medical Angels
- Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
- Air Charity Network
- Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
- Ronald McDonald House
- Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
- Healthcare Hospitality Network
- Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.
Program details were checked on each program's website on October 24, 2026.
Questions about finding a Geographic Atrophy trial near you
Are there Geographic Atrophy clinical trials near me?
As of November 13, 2026, 42 Geographic Atrophy clinical trials are recruiting now and 10 are not yet recruiting. In the US, 35 of them have at least 1 open site, across 39 states. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Geographic Atrophy clinical trial sites?
Recruiting Geographic Atrophy trials list open sites in 39 states. Texas, California and Pennsylvania have the most, and the table on this page lists every state.
Are there Geographic Atrophy trials for children near me?
Of the 35 Geographic Atrophy trials with a US site, 1 accepts children under 18. Its open sites are in Pennsylvania. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.
Who pays for travel to a Geographic Atrophy clinical trial?
Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights.
What if there is no Geographic Atrophy trial near me?
Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Geographic Atrophy trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Geographic Atrophy: Izervay (avacincaptad pegol), Syfovre (pegcetacoplan injection (intravitreal)).
Clinical trials near you for related conditions
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.